References
- Elharram M, Margel D, Finelli A, et al. Perineural invasion on prostate biopsy does not predict adverse pathological outcome. Can J Urol. 2012;19:6567–6572.
- Goldberg H, Ramiz AH, Glicksman R, et al. Extraprostatic extension in Core biopsies epitomizes high-risk but locally treatable prostate cancer. Eur Urol Oncol. 2019;2:88–96.
- Ball MW, Partin AW, Epstein JL. Extent of extraprostatic extension independently influences biochemical recurrence-free survival: evidence for further pT3 subclassification. Urology. 2015;85:161–164.
- Ahmad AS, Parameshwaran V, Beltran L, et al. Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? Correlation with outcome in biopsy cases treated conservatively. Oncotarget. 2018;9:20555–20562.
- Srigley JR, Humphrey PA, Amin MB, et al. Protocol for the examination of specimens from patients with carcinoma of the prostate gland. Arch Pathol Lab Med. 2009;133:1568–1576.
- Siddiqui MM, Rais-Bahrami S, Turkbey B, et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound – guided biopsy for the diagnosis of prostate cancer. JAMA. 2015;313:390–397.
- Loeb S, Epstein JI, Humphreys EB, et al. Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes?. BJU Int. 2010;105:1510–1513.
- Roach M, 3rd, Hanks G, Thames H, Jr, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys.2006;65:965–974.
- O’Malley KJ, Pound CR, Walsh PC, et al. Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy. Urology. 2002;59:85–90.
- de la Taille A, Rubin MA, Bagiella E, et al. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?. J Urol. 1999;162:103–106.
- D’Amico AV, Wu Y, Chen MH, et al. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. J Urol. 2001;165:126–129.
- Harnden P, Shelley MD, Clements H, et al. The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review. Cancer. 2007;109:13–24.
- Katz B, Srougi M, Dall’Oglio M, et al. Perineural invasion detection in prostate biopsy is related to recurrence-free survival in patients submitted to radical prostatectomy. Urol Oncol. 2013;31:175–179.
- Cozzi G, Rocco BM, Grasso A, et al. Perineural invasion as a predictor of extraprostatic extension of prostate cancer: a systematic review and meta – analysis. Scand J Urol. 2013;47:443–448.
- De Lancey JO, Wood DP Jr, He C, et al. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy. Urology. 2013;81:354–357.
- Haki Yuksel O, Urkmez A, Verit A. Can perineural invasion detected in prostate needle biopsy specimens predict surgical margin positivity in D’Amico low risk patients? Arch Ital Urol Androl. 2016;88:89–92.
- Lubig S, Thiesler T, Müller S, et al. Quantitative perineural invasion is a prognostic marker in prostate cancer. Pathology. 2018;50:298–304.
- Fleshner K, Assel M, Benfante N, et al. Clinical findings and treatment outcomes in patients with extraprostatic extension identified on prostate biopsy. J Urol. 2016;196:703–708.